Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, T-Cell, Peripheral 4Melanoma 3Neoplasms 2Lymphoproliferative Disorders 2Lymphoma 2Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Pancreatic Neoplasms 1Neoplasms by Histologic Type 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphatic Diseases 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Myeloid, Acute 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

ponatinib 4pembrolizumab 3Rituximab 3Gemcitabine 3Cyclophosphamide 3130-nm albumin-bound paclitaxel 3pralsetinib 2napabucasin 2Vincristine 2Prednisone 2Irinotecan 2Imatinib Mesylate 2Etoposide 2Doxorubicin 2Carboplatin 2Brentuximab Vedotin 2tetulomab tetraxetan lu-177 1ruxolitinib 1ricolinostat 1pomalidomide 1pamiparib 1nirogacestat 1nilotinib 1ibritumomab tiuxetan 1denileukin diftitox 1bosutinib 1blinatumomab 1Vorinostat 1Temozolomide 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neoplasms by Histologic Type × denileukin diftitox × Clear all
NCT01401530 2018-11-23

E7777 for the Treatment of Patients With Peripheral T-Cell Lymphoma

Eisai Inc.

Phase 1 Completed
13 enrolled 18 charts
Lymphoid

Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡